MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

Search

Treace Medical Concepts Inc

Fechado

2.52 1.2

Visão Geral

Variação de preço das ações

24h

Atual

Mín

2.4

Máximo

2.54

Indicadores-chave

By Trading Economics

Rendimento

1.1M

-16M

Vendas

2.8M

50M

Margem de lucro

-32.437

Funcionários

477

EBITDA

1.3M

-12M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+113.6% upside

Dividendos

By Dow Jones

Próximos Ganhos

26 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-248M

168M

Abertura anterior

1.32

Fecho anterior

2.52

Pontuação Técnica

By Trading Central

Confiança

Strong Bullish Evidence

Treace Medical Concepts Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de jan. de 2026, 23:49 UTC

Ações em Alta

Stocks to Watch: Agilysys, Nucor, Humana, UnitedHealth

26 de jan. de 2026, 23:09 UTC

Grandes Movimentos do Mercado

Health Insurers' Shares Fall After Government Proposes Flat Medicare Advantage Rate

26 de jan. de 2026, 23:52 UTC

Conversa de Mercado

Gold's Path of Least Resistance Still Looks Higher, Technical Analysis Shows -- Market Talk

26 de jan. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Decline as Yen's Rebound Raises Caution Over Earnings -- Market Talk

26 de jan. de 2026, 23:37 UTC

Conversa de Mercado

Gold Rises Amid Concerns Over Tariffs -- Market Talk

26 de jan. de 2026, 22:41 UTC

Conversa de Mercado

Australian 4Q CPI To Provide Smoking Gun For Hike -- Market Talk

26 de jan. de 2026, 22:26 UTC

Ganhos

Karoon Expects Capex of US$110 Million-US$135 Million in 2026

26 de jan. de 2026, 22:26 UTC

Ganhos

Karoon Expects Operating Costs to Fall Once Transition of Bauna FPSO Operatorship Completes

26 de jan. de 2026, 22:25 UTC

Ganhos

Karoon Energy Expects Unit Production Cost of US$12-US$15/BOE in 2026

26 de jan. de 2026, 22:25 UTC

Ganhos

Karoon Energy Expects Output to Rise in 2H Following Bauna Investment Program

26 de jan. de 2026, 22:25 UTC

Ganhos

Karoon Energy Expects Output of 8.1 Million-9.2 Million BOE in 2026

26 de jan. de 2026, 22:24 UTC

Ganhos

Karoon Energy 4Q Sales Revenue US$156.1 Million

26 de jan. de 2026, 22:23 UTC

Ganhos

Karoon Energy 4Q Sales Volumes 2.65 Million BOE, Up 5% on Quarter

26 de jan. de 2026, 22:23 UTC

Ganhos

Karoon Energy: Bauna FPSO Efficiency Increased to 98.8%

26 de jan. de 2026, 22:23 UTC

Ganhos

Karoon Energy FY Oil, Natural Gas Production 10.3 Million BOE

26 de jan. de 2026, 22:22 UTC

Ganhos

Karoon Energy 4Q Oil, Natural Gas Production 2.37 Million BOE

26 de jan. de 2026, 22:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Fortescue: Alta Copper Shareholders Approve Takeover

26 de jan. de 2026, 22:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Senate Antitrust Panel Chair Raises Concerns Over Netflix-Warner Deal -- WSJ

26 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Financial Services Roundup: Market Talk

26 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

26 de jan. de 2026, 21:34 UTC

Ganhos

Nucor: Steel Products Segment Expected Improved Earnings in 1Q Due to Increased Volumes on Stable Pricing >NUE

26 de jan. de 2026, 21:34 UTC

Ganhos

Nucor: Steel Mills Segment Expected Increase Is Due to Higher Volumes and Higher Realized Prices Across All Major Pdt Categories >NUE

26 de jan. de 2026, 21:34 UTC

Ganhos

Nucor: Raw Materials Segment Is Expected to Have Increased Earnings in 1Q >NUE

26 de jan. de 2026, 21:34 UTC

Ganhos

Nucor: 1Q Earnings Expected to Increase Across All Three Operating Segments, With the Largest Increase in Steel Mills Segment >NUE

26 de jan. de 2026, 21:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Eaton Stock Rises on Spin-Off Plan. Why It's Going All-In on Planes and AI Data Centers. -- Barrons.com

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q Sales $7.69B >NUE

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q Net $378M >NUE

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q Steel Mills Total Shipments 5.91M Tons >NUE

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q Total Tons Shipped to Outside Customers Down 9% >NUE

26 de jan. de 2026, 21:30 UTC

Ganhos

Nucor 4Q EPS $1.64 >NUE

Comparação entre Pares

Variação de preço

Treace Medical Concepts Inc Previsão

Preço-alvo

By TipRanks

113.6% parte superior

Previsão para 12 meses

Média 5.34 USD  113.6%

Máximo 7.5 USD

Mínimo 3 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Treace Medical Concepts Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

6 ratings

1

Comprar

4

Manter

1

Vender

Pontuação Técnica

By Trading Central

7.16 / 7.65Suporte e Resistência

Curto Prazo

Strong Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bullish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Treace Medical Concepts Inc

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
help-icon Live chat